Neurol. praxi. 2010;11(6):428-429

Léčba valproátem v populaci mladých žen

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Léčba valproátem v populaci mladých žen. Neurol. praxi. 2010;11(6):428-429.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75(11): 1575-1583. Go to original source... Go to PubMed...
    2. Meador KJ, Baker GA, Browning N, Clayton-Smith J, CombsCantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009; 360(16): 1597-1605. Go to original source... Go to PubMed...
    3. McVearry KM, Gaillard WD, VanMeter J, Meador KJ. A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav. 2009; 16(4): 609-616. Epub 2009 Nov 4. Go to original source... Go to PubMed...
    4. Herndandez-Diaz S, Mittendorf R, Holmes LB. Comparative Safety of Topiramate During Pregnancy. Birth Defects Research (Part A); 88: 408 (2010).
    5. ##
    6. Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults, expert opinion, 2005. Epilepsy Behav 2005; 7: S1-64. Go to original source... Go to PubMed...
    7. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 2007; 369(9566): 1016-1026. Go to original source... Go to PubMed...
    8. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009; 360: 1597-1605. Go to original source... Go to PubMed...
    9. Montorious G, Abou Khalil B. The first line of therapy in a girl with juvenile myoclonic epilepsy: Should it be valproate or a new agent? Epilepsia 2009; 50(Suppl. 8): P16-20. Go to original source... Go to PubMed...
    10. Morrow J, Russell A, Guthrie E, et al. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77: 193-198. Go to original source... Go to PubMed...
    11. The EURAP Study Group. Seizure control and treatment in pregnancy: Observation from the EURAP Epilepsy Pregnancy Registry. Neurology 2006; 66: 354-360. Go to original source... Go to PubMed...
    12. Vajda FJ, O'Brien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004; 11: 854-858. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.